Program Description:
Diabetes affects 23.6 million people (7.8% of the U.S population) and its prevalence is increasing. Prevalence increases with age, reaching 21.6% for those 65 years of age or older. A further 25.9% of adults and 7% of adolescents have pre-diabetes, characterized by impaired fasting glucose. Patients are at increased risk for microvascular and macrovascular complications, depending upon the duration of diabetes and degree of hyperglycemia. Complications include heart disease, hypertension, stroke, retinopathy, kidney disease, nerve damage, amputation, periodontitis, and complications of pregnancy. We could do better in the recognition and treatment of patients with diabetes. Early diagnosis and treatment reduces the risk of complications and improves outcomes in diabetes. However, 5.7 million cases of diabetes in the United States are undiagnosed and therefore not receiving treatment. Appropriate management choices are required for optimal outcomes in diabetes. However, prescription of medication is often inappropriate. Glycemic control reduces microvascular and neuropathic complications. However, up to two-thirds of people with type-2 diabetes may not achieve glycemic targets, and only 7% of patients may meet all 3 targets involving A1C, blood pressure and LDL-C. The objectives of this CME activity address these gaps and will enable health care providers to improve their treatment of patients with diabetes.
Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care Update: 2012 conference. The topic of this webcast is Case Studies in Type 2 Diabetes.
The program was captured live in Denver, Colorado on June 16, 2012 and features Dr. Mark Stolar. Dr. Stolar is an Assistant Professor of Clinical Medicine at the Feinberg School of Medicine at Northwestern University in Chicago, IL.
INTENDED AUDIENCE:
Primary care providers
Activity Objectives:
After completing this program, participants should be able to:
- Address the importance of early diagnosis for enhancing outcomes in type 2 diabetes
- Identify evidence-based strategies for type 2 diabetes management
- Discuss the role of newer therapies in the pathophysiology and management of type 2 diabetes
- Discuss the role of the chronic care model in optimizing diabetes care
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
1.00
|
AMA PRA Category 1 Credit(s)TM
|
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
|
The National Association for Continuing Education designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
Faculty:
Mark Stolar, MD
Associate Professor of Clinical Medicine
Feinberg School of Medicine Northwestern University
Chicago, IL
Disclosures:
Faculty Disclosure Policy
Mark Stolar, MD, Speaker, is on the advisory board for Takeda and Sanofi Aventis and on the speakers's bureau for Takeda.
Robert S. Busch, MD, FACE, Speaker, is on the speaker's bureau for Amylin, NovoNordisk and Takeda.
Frank Lavernia, MD, Speaker,is on the advisory Committee for Sanofi Aventis and the speaker's bureau for Abbott and NovoNordisk.
Harvey C. Parker, Ph.D., Activity Planning Committee, has the following relationship to disclose: co-owner of Specialty Press, Inc. and Health Link Systems, Inc.
Gregg Sherman, MD, Co-Course Director, has no relationships to disclose.
Deborah Paschal, CRNP, Co-Course Director, has no relationships to disclose.
Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Accredited Provider:
National Association for Continuing Education
Commercial Supporter:
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. which was made possible, in part, through a collaboration with Eli Lilly and Company and an educational grant from Novo Nordisk.
Instructions:
To obtain credit, a score of 60% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test, and received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.